BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29954328)

  • 1. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.
    Li X; Huang Y; Xu Z; Zhang R; Liu X; Li Y; Mao P
    BMC Infect Dis; 2018 Jun; 18(1):289. PubMed ID: 29954328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
    Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
    J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus reactivation in critically ill immunocompetent patients.
    Limaye AP; Kirby KA; Rubenfeld GD; Leisenring WM; Bulger EM; Neff MJ; Gibran NS; Huang ML; Santo Hayes TK; Corey L; Boeckh M
    JAMA; 2008 Jul; 300(4):413-22. PubMed ID: 18647984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cytomegalovirus reactivation on clinical outcomes in immunocompetent critically ill patients: protocol for a systematic review and meta-analysis.
    Lachance P; Chen J; Featherstone R; Sligl W
    Syst Rev; 2016 Jul; 5(1):127. PubMed ID: 27465807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
    Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
    Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
    Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
    JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection in critically ill patients: a systematic review.
    Osawa R; Singh N
    Crit Care; 2009; 13(3):R68. PubMed ID: 19442306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
    Cowley NJ; Owen A; Shiels SC; Millar J; Woolley R; Ives N; Osman H; Moss P; Bion JF
    JAMA Intern Med; 2017 Jun; 177(6):774-783. PubMed ID: 28437539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Lachance P; Chen J; Featherstone R; Sligl WI
    Open Forum Infect Dis; 2017; 4(2):ofx029. PubMed ID: 29497626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.
    Heininger A; Haeberle H; Fischer I; Beck R; Riessen R; Rohde F; Meisner C; Jahn G; Koenigsrainer A; Unertl K; Hamprecht K
    Crit Care; 2011; 15(2):R77. PubMed ID: 21362193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.
    Ong DSY; Spitoni C; Klein Klouwenberg PMC; Verduyn Lunel FM; Frencken JF; Schultz MJ; van der Poll T; Kesecioglu J; Bonten MJM; Cremer OL
    Intensive Care Med; 2016 Mar; 42(3):333-341. PubMed ID: 26415682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome*.
    Ong DS; Klein Klouwenberg PM; Verduyn Lunel FM; Spitoni C; Frencken JF; Dekker HA; Schultz MJ; Bonten MJ; Cremer OL
    Crit Care Med; 2015 Feb; 43(2):394-400. PubMed ID: 25377020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinical characteristics and risk factors of cytomegalovirus reactivation in immunocompetent patients in respiratory intensive care unit].
    Wang X; Liu YN; Jin Z; Huang JJ; Huang JF; Liao JP; Ma J; Wang GF
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3168-3171. PubMed ID: 31694109
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytomegalovirus reactivation in ICU patients.
    Papazian L; Hraiech S; Lehingue S; Roch A; Chiche L; Wiramus S; Forel JM
    Intensive Care Med; 2016 Jan; 42(1):28-37. PubMed ID: 26424680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus reactivation in critically ill immunocompetent patients.
    Libert N; Bigaillon C; Chargari C; Bensalah M; Muller V; Merat S; de Rudnicki S
    Biomed J; 2015; 38(1):70-6. PubMed ID: 25179711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
    Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
    Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus colitis in immunocompetent critically ill patients.
    Siciliano RF; Castelli JB; Randi BA; Vieira RD; Strabelli TM
    Int J Infect Dis; 2014 Mar; 20():71-3. PubMed ID: 24406737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Pulmonary Aspergillosis and
    Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in patients with sepsis due to bloodstream infections: lower risk and better outcomes in new versus already hospitalised intensive care unit admissions.
    Osawa R; Wagener M; Singh N
    Anaesth Intensive Care; 2016 Sep; 44(5):571-80. PubMed ID: 27608339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
    van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
    Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.